LitAlert ~~

    • Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors.
    • Peyraud F, Italiano A.
    • Cancers (Basel). 2020 Jun 9;12(6):E1502. doi: 10.3390/cancers12061502.
    • Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.
    • Zhu M, Mohamad S, Halfdanarson T, Hobday T, Ahn D, Ma WW, Bekaii-Saab T.
    • Oncologist. 2020 Jun 8. doi: 10.1634/theoncologist.2020-0029. Epub ahead of print.